Clinical Trials Browser

Interventional × Breast Neoplasms × Telmisartan × Clear all

NCT07370506 2026-01-29

Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients

Phase 1/2 Not yet recruiting

Breast Neoplasms

NCT05322889 2024-08-28

PrevTel

Phase 2 Completed

BreastGynecologic

Breast Neoplasms, Neuralgia, Ovarian Neoplasms